|
Clerk of the House of Representatives Legislative Resource Center 135 Cannon Building Washington, DC 20515 http://lobbyingdisclosure.house.gov |
Secretary of the Senate Office of Public Records 232 Hart Building Washington, DC 20510 http://www.senate.gov/lobby |
LOBBYING REGISTRATION
Lobbying Disclosure Act of 1995 (Section 4)
| 1. Effective Date of Registration | 7/20/2018 |
||||
| 2. House Identification | 312040147 |
Senate Identification | 35230-1003961 |
||
REGISTRANT Organization/Lobbying Firm Self Employed Individual
| 3. Registrant | Organization | Sidley Austin LLP |
||||
| Address | 1501 K Street |
Address2 |
|
| City | Washington |
State | DC |
Zip | 20005 |
Country | USA |
4. Principal place of business (if different than line 3)
| City |
|
State |
|
Zip |
|
Country |
|
| 5. Contact name and telephone number | International Number |
| Contact | Mr. Michael Nemeroff |
Telephone | 2027368235 |
mlyles@sidley.com |
CLIENT A Lobbying Firm is required to file a separate registration for each client. Organizations employing in-house lobbyists should check the box labeled “Self” and proceed to line 10. Self
| 7. Client name | Medical Information Working Group |
| Address | 2099 Pennsylvania Avenue, NW |
| City | Washington |
State | DC |
Zip | 20006-6807 |
Country | USA |
| City | Washington |
State | DC |
Zip | 20006-6807 |
Country | USA |
LOBBYISTS
10. Name of each individual who has acted or is expected to act as a lobbyist for the client identified on line 7. If any person listed in this section has served as a “covered executive branch official” or “covered legislative branch official” within twenty years of first acting as a lobbyist for the client, state the executive and/or legislative position(s) in which the person served.
| Name | Covered Official Position (if applicable) | ||
First |
Last |
Suffix |
|
| Paul | Kalb | | N/A |
| | | | |
| | | | |
| | | | |
| | | | |
LOBBYING ISSUES
11. General lobbying issue areas (Select all applicable codes).
HCR |
|
|
|
|
|
|
|
|
12. Specific lobbying issues (current and anticipated)
DOJ policy regarding off label communications
AFFILIATED ORGANIZATIONS
13. Is there an entity other than the client that contributes more than $5,000 to the lobbying activities of the registrant in a quarterly period and either participates in and/or in whole or in major part supervises or controls the registrant’s lobbying activities?
| No --> Go to line 14. | Yes --> Complete the rest of this section for each entity matching the criteria above, then proceed to line 14. |
| Internet Address: |
|
| Name | Address | Principal Place of Business | ||||||||
| Street | ||||||||||
|
||||||||||
Amgen Inc. |
601 13th St NW |
|
||||||||
|
|
|||||||||
Bayer Healthcare Pharmaceuticals Inc. |
100 Bayer Boulevard |
|
||||||||
|
|
|||||||||
Eli Lilly and Company |
Lilly Corporate Center |
|
||||||||
|
|
FOREIGN ENTITIES
14. Is there any foreign entity
a) holds at least 20% equitable ownership in the client or any organization identified on line 13; or
b) directly or indirectly, in whole or in major part, plans, supervises, controls, directs, finances or subsidizes activities of the client or any organization identified on line 13; or
c) is an affiliate of the client or any organization identified on line 13 and has a direct interest in the outcome of the lobbying activity?
| No --> Sign and date the registration. | Yes --> Complete the rest of this section for each entity matching the criteria above, then sign the registration. |
| Address | Ownership | |||||
| Name | Street | Principal place of business | Amount of contribution | |||
|
(city and state or country) | for lobbying activities | ||||
Clonshaugh Business and Technology Park |
|
|||||||||||
Allergan plc |
|
|
0.00 |
0 |
% | |||||||
Binger Str. 173,55216 |
|
|||||||||||
Bayer AG |
|
|
0.00 |
0 |
% |
| Signature | Digitally Signed By: Paul E. Kalb, M.D. |
Date | 8/29/2018 4:08:39 PM |
10. Supplemental. List any additional lobbyists for this client not listed on page 1, number 10.
| Name | Covered Official Position (if applicable) | Have you been convicted of a crime? | ||
First |
Last |
Suffix |
||
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
|
|
|
|
|
|
|
|
|
| Name | Address | Principal Place of Business | ||||||||
| Street | ||||||||||
|
||||||||||
Genentech, Inc. |
1 DNA Way Mailstop 258A |
|
||||||||
|
|
|||||||||
GlaxoSmithKline LLC |
5 Crescent Drive |
|
||||||||
|
|
|||||||||
Johnson & Johnson Services |
One Johnson & Johnson Plaza |
|
||||||||
|
|
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership | ||||||||||||||
| ||||||||||||||||||
Boehringer Ingelheim International GmbH |
|
|
0 |
0 % |
||||||||||||||
GlaxoSmithKline, PLC |
|
|
0 |
0 % |
||||||||||||||
Sanofi-Aventis SA |
|
|
0 |
0 % |
||||||||||||||
10. Supplemental. List any additional lobbyists for this client not listed on page 1, number 10.
| Name | Covered Official Position (if applicable) | Have you been convicted of a crime? | ||
First |
Last |
Suffix |
||
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
|
|
|
|
|
|
|
|
|
| Name | Address | Principal Place of Business | ||||||||
| Street | ||||||||||
|
||||||||||
Pfizer, Inc. |
235 East 42nd Street |
|
||||||||
|
|
|||||||||
Sanofi US Services Inc. |
55 Corporate Drive |
|
||||||||
|
|
|||||||||
Novartis Pharmaceutical Corporation |
One Health Plaza |
|
||||||||
|
|
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership | ||||||||||||||
| ||||||||||||||||||
Roche Holdings AG |
|
|
0 |
0 % |
||||||||||||||
Novartis AG |
|
|
0 |
0 % |
||||||||||||||
|
|
|
|
% |
||||||||||||||
10. Supplemental. List any additional lobbyists for this client not listed on page 1, number 10.
| Name | Covered Official Position (if applicable) | Have you been convicted of a crime? | ||
First |
Last |
Suffix |
||
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
|
|
|
|
|
|
|
|
|
| Name | Address | Principal Place of Business | ||||||||
| Street | ||||||||||
|
||||||||||
Bristol-Myers Squibb Company |
345 Park Ave |
|
||||||||
|
|
|||||||||
Boehringer Ingelheim Pharmaceuticals, Inc. |
900 Ridgebury Road |
|
||||||||
|
|
|||||||||
Samumed, LLC |
9381 Judicial Drive Suite 160 |
|
||||||||
|
|
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership | ||||||||||||||
| ||||||||||||||||||
|
|
|
|
% |
||||||||||||||
|
|
|
|
% |
||||||||||||||
|
|
|
|
% |
||||||||||||||